Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ALLERGAN PLC
01/13 ALLERGAN : Evolus Files for IPO Ahead of Potential 2018 Approval for Botox Alter..
01/11 ALLERGAN : 2 Reasons Why Allergan Stock Plunged in 2017
01/09 U.S. pharma executives expect deals to pick up after tax overhaul
01/09 ALLERGAN PLC (NYSE : AGN) Files An 8-K Results of Operations and Financial Condi..
01/08 ALLERGAN : Provides 2018 Preliminary Financial Outlook for Select Income Stateme..
01/08 ALLERGAN : to Report Fourth Quarter and Full Year 2017 Earnings and Host Confere..
01/03 ALLERGAN : to cut over 1,000 jobs as it works to cut costs
01/03 Pershing Square, Valeant to appear in court on insider trading suit settlemen..
01/03 Allergan among companies unveiling price hikes
01/03 ALLERGAN PLC (NYSE : AGN) Files An 8-K Entry into a Material Definitive Agreemen..
01/03 Pershing Square, Valeant to appear in court on insider trading suit settlemen..
2017 Pershing Square, Valeant arrive at settlement split for Allergan lawsuit
2017 ALLERGAN : to Present at the 36th Annual J.P. Morgan Healthcare Conference
2017 ALLERGAN : Acknowledges Appeals Court Decision for COMBIGAN
2017 ALLERGAN : to Present at the 36th Annual J.P. Morgan Healthcare Conference
2017 ALLERGAN : Acknowledges Appeals Court Decision for COMBIGAN®
2017 ALLERGAN : Succession doubts cloud Apotex future after billionaire owner's death
2017 ALLERGAN : Succession doubts cloud Apotex future after billionaire owner's death
2017 ALLERGAN : VISTABEL Receives Positive Opinion from ANSM for Treatment of Moderat..
2017 ALLERGAN : FDA Accepts NDA For Acne Drug Seysara
2017 ALLERGAN : Announces Promotion of Wayne Swanton to Executive Vice President, Glo..
2017 ALLERGAN : and Richter Announce Positive Topline Results from Phase 3 Study of C..
2017 ALLERGAN : VISTABEL® (botulinum toxin type A) Receives Positive Opinion from ANS..
2017 ALLERGAN PLC (NYSE : AGN) Files An 8-K Departure of Directors or Certain Officer..
2017 TEVA PHARMACEUTICAL INDUSTRIES : Union says workers at Israeli drugs firm Teva t..
2017 TEVA PHARMACEUTICAL INDUSTRIES : Union says workers at Israeli drugs firm Teva t..
2017 ALLERGAN : and Richter Announce Positive Topline Results from Phase 3 Study of C..
2017 ALLERGAN : Announces Promotion of Wayne Swanton to Executive Vice President, Glo..
2017 TEVA PHARMACEUTICAL INDUSTRIES : Strike over Teva Pharm job cuts briefly shuts d..
2017 ALLERGAN : Receives FDA Clearance for the CoolSculpting Treatment to Improve App..
2017 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
2017 ALLERGAN : Receives FDA Clearance For the CoolSculpting® Treatment To Improve Ap..
2017 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
2017 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
2017 EDITAS MEDICINE : BioCentury - Editas raises $50M follow-on
2017 Tech firms tell patent court to ignore Allergan deal with tribe
2017 ALLERGAN : Health Care Up on Rotation Out of Tech -- Health Care Roundup
2017 ALLERGAN : Migraine Leadership Recognized with Enrico Greppi Award for Excellenc..
2017 ALLERGAN : to Present at the 2017 Citi Global Healthcare Conference
2017 ALLERGAN : to Present at the 2017 Citi Global Healthcare Conference
2017 ALLERGAN : to Present at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conf..
2017 ALLERGAN : Overactive Bladder Causes Significant Burden Regardless of Age Amongs..
2017 ALLERGAN PLC : ex-dividend day
2017 ALLERGAN : Receives FDA Approval for Use of VRAYLAR in the Maintenance Treatment..
2017 ALLERGAN : Overactive Bladder Causes Significant Burden, Regardless of Age Among..
2017 ALLERGAN : to sell a quarter of its Teva stake in first quarter 2018
2017 Pfizer creates chief operating officer role for Bourla
2017 ALLERGAN : Receives FDA Approval For Use of VRAYLAR™ (cariprazine) in the ..
2017 Novartis posts eye drug data amid play for Eylea's turf
2017 AMGEN : And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevac..
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 15 892 M
EBIT 2017 7 639 M
Net income 2017 -6 499 M
Debt 2017 24 902 M
Yield 2017 1,63%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 5,25x
EV / Sales 2018 5,32x
Capitalization 58 551 M
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | AGN | IE00BY9D5467 | 4-Traders
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 220 $
Spread / Average Target 25%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC7.62%58 551
JOHNSON & JOHNSON4.32%391 587
NOVARTIS1.80%225 838
ROCHE HOLDING LTD.-0.28%218 350
PFIZER0.88%217 804
MERCK AND COMPANY4.25%159 987